• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Neurology

Age not associated with differences in radiosurgical arteriovenous malformation outcomes

byDaniel LeeandChaz Carrier
May 22, 2015
in Neurology, Surgery
Reading Time: 2 mins read
Age not associated with differences in radiosurgical arteriovenous malformation outcomes
Share on FacebookShare on TwitterShare on LinkedIn

1. There was no difference between elderly patients (≥60 years) and non-elderly patients in the occurrence of adverse outcomes following radiosurgery for arteriovenous malformation.

2. Elderly age was not predictive of arteriovenous malformation obliteration, radiation-induced changes or hemorrhage following radiosurgery.

Evidence Rating Level: 2 (Good)

Study Rundown: Cerebral arteriovenous malformation (AVM) is uncommon among elderly patients; however, the incidence is rising in concert with increases in life expectancy. While previous studies have shown that age is associated with worse surgical outcomes, there is a shortage of evidence on post-radiosurgery outcomes in the elderly population. This study aimed to analyze and characterize outcomes following radiosurgical AVM treatment in elderly patients. The authors found that the achievement of AVM obliteration was similar between the elderly (≥60 years) and non-elderly cohorts. Likewise, there was no difference in the occurrence of radiation-induced changes (RIC). The incidence rate of post-radiosurgery hemorrhage was comparable between the elderly and non-elderly cohorts as well. Elderly age was not a significant predictor for AVM obliteration, RIC and post-radiosurgery hemorrhage. This study was strengthened by the use of multiple outcome measures and matching cohorts. However, this study was limited by its retrospective, single-center design and potential selection and treatment bias.

Click to read the study in World Neurosurgery

Relevant Reading: Results for a Series of 697 Arteriovenous Malformations Treated by Gamma Knife: Influence of Angiographic Features on the Obliteration Rate

RELATED REPORTS

Real-time AI guidance enters live brain tumor surgery

Burr hole craniotomy for chronic subdural hematoma under local anesthesia may reduce risks of postoperative delirium compared to general anesthesia

In-Depth [retrospective cohort]: Researchers reviewed 132 AVM patient files, with 66 patients in each of the elderly and non-elderly cohorts. Patients were treated with stereotactic radiosurgery at the University of Virginia between 1989 and 2013. The inclusion criteria for the elderly cohort were as follows: 1) patient age 60 years or more 2) sufficient clinical and patient data 3) minimum of 2 years radiologic follow-up or complete AVM obliteration. Propensity score matching was used to match elderly AVM patients to non-elderly subjects in a 1:1 fashion based on clinical features related to AVM, such as nidus volume and AVM location. Outcomes included achievement of AVM obliteration, presence of RIC, and the occurrence of AVM-related hemorrhage. There were no differences in the baseline characteristics between two cohorts with the exception of age, the number of isocenters in the treatment plan, and a radiosurgery AVM score system, which incorporated age in its formula. There was no difference in the rate of AVM obliteration between the elderly and the non-elderly cohorts (66.7% vs. 69.7%, respectively, p = 0.709). In addition, there was no significant difference in the rates of radiographically evident, symptomatic and permanent RIC between the 2 groups (p = 0.188, 0.345, 0.316, respectively). Lastly, the rate of hemorrhage was not significantly different between the elderly and the non-elderly cohorts (1.1% vs. 2.0%, p = 0.300). Elderly age was not found to be significant predictor for any of the outcome measures.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: arteriovenous malformationneurosurgery
Previous Post

FDG-PET may guide antibiotic therapy in vascular graft infections

Next Post

Single motherhood associated with poorer health outcomes in late adulthood

RelatedReports

An artistic illustration featuring an elderly woman with a brain overlay, an open book suggesting knowledge or guidance, and various medical symbols related to neurology and surgery.
Imaging and Intervention

Real-time AI guidance enters live brain tumor surgery

September 11, 2026
Chronic Disease

Burr hole craniotomy for chronic subdural hematoma under local anesthesia may reduce risks of postoperative delirium compared to general anesthesia

March 18, 2026
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Emergency

Screening for acute ischemic stroke using the Los Angeles Motor Scale may be feasible and improve time to imaging

January 13, 2026
Age not associated with differences in radiosurgical arteriovenous malformation outcomes
Neurology

Surgical and conservative management strategies for acute subdural hematoma are associated with similar functional outcomes

January 13, 2026
Next Post
Maternal verbal interaction more common than paternal during infancy

Single motherhood associated with poorer health outcomes in late adulthood

Alzheimer disease diagnoses aided by amyloid positive PET scans

Alzheimer disease diagnoses aided by amyloid positive PET scans

Surgical site anesthetic infusion may enhance analgesia after mastectomy

Higher antibiotic dose for C-section prophylaxis in obese

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Routine CT scans show steeper fat loss years before pancreatic cancer diagnosis
  • Post-hoc CHARM analysis linked CIRARA with better functional outcomes in selected patients with severe stroke
  • Zemprocitinib sustained clinical responses through Week 76 in rheumatoid arthritis after inadequate response to biologic therapy
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.